These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trial of amantadine in Parkinson's disease. Campbell AM; Williams MJ Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563 [No Abstract] [Full Text] [Related]
3. [Amantadine treatment in parkinsonism]. Holmsen R Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984 [No Abstract] [Full Text] [Related]
4. Coloured Lilliputian hallucinations with amantadine. Harper RW; Knothe BU Med J Aust; 1973 Mar; 1(9):444-5. PubMed ID: 4708929 [No Abstract] [Full Text] [Related]
5. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease. Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118 [No Abstract] [Full Text] [Related]
6. [Amantadine in the treatment of Parkinson's disease]. Penders C Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353 [No Abstract] [Full Text] [Related]
7. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Postma JU; Van Tilburg W J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540 [TBL] [Abstract][Full Text] [Related]
8. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]
9. Drug-induced delusions of parasitosis during treatment of Parkinson's disease. Swick BL; Walling HW J Am Acad Dermatol; 2005 Dec; 53(6):1086-7. PubMed ID: 16310077 [No Abstract] [Full Text] [Related]